期刊文献+

左乙拉西坦单药治疗不同类型婴幼儿癫痫的临床效果和安全性 被引量:4

Effect and safety of levetiracetam in treatment of different types of infant epilepsy
暂未订购
导出
摘要 目的 探析不同类型婴幼儿癫痫应用左乙拉西坦单药治疗的临床效果和安全性.方法 选取本院2011年1月~2012年12月收治的50例不同类型婴幼儿癫痫患儿作为观察对象,入院后应用左乙拉西坦单药治疗,2次/d,服用起始总剂量为10mg/(kg·d),根据患者的实际病情每5日增加5~10 mg/(kg·d),维持治疗剂量为20~40mg/(kg·d),约2周平均剂量增加到35mg/(kg·d),观察50例患者的临床症状改变情况和不良反应发生情况.结果 50例患者均完成了药物治疗,其中显效26例,有效14例,无效10例,总有效率为80.0%,患者有情绪焦躁、行为异常和嗜睡的不良反应.结论 不同类型婴幼儿癫痫患儿应用左乙拉西坦治疗有明显的治疗效果,特别是部分型和肌阵挛发作患儿治疗效果良好,药物治疗过程中不良反应发生少,是一种安全有效的抗癫痫药物,可以在临床推广. Objective To explore the effect and safety of levetiracetam in treatment of different types of infant epilepsy. Methods 50 cases of children with different types of infant epilepsy,who were treated in our hospital from January 2011 to December 2012,were selected as research objects.They were given levetiracetam 10 mg/(kg.d) twice a day for initial total dose after admission.And then,according to actual condition of patients,doses were increased with 5 to 10 mg/(kg.d) per 5 days. 20 to 40 mg/(kg.d) were regarded as maintenance treatment dose,the average dose increased to 35 mg/(kg .d) in about 2 weeks.Clinical symptoms change and adverse reactions occurrence of 50 patients were observed. Results All the 50 cases completed drug therapy,significantly improved in 26 cases,improved in 14 cases,and invalid in 10 cases.The effective rate was 80% .Patients had adverse reactions with anxiety,abnormal behavior and drowsiness. Conclusion Levetiracetam has an obvious therapeutic effect in treatment of different types of infant epilepsy,especially the part type and myoclonic seizure children.Less adverse reaction occurred in the process of drug treatment,so it is a safe and effective antiepileptic drug,it can be widely applied in clinic.
作者 吴仕站
出处 《中国当代医药》 2013年第35期70-71,共2页 China Modern Medicine
关键词 婴幼儿癫痫 左乙拉西坦 临床疗效 安全性 Infant epilepsy Levetiracetam Clinical therapeutic effect Safety
  • 相关文献

参考文献14

二级参考文献77

  • 1张宏卫,刘丽华,李士新,薛艺东,李伟.妥泰单药治疗癫痫的临床疗效观察[J].临床荟萃,2002,17(24):1447-1449. 被引量:8
  • 2黄铁栓,朱金兰,李冰,胡雁,廖建湘.抗癫痫药物加重儿童癫痫发作的临床研究[J].中国当代儿科杂志,2004,6(5):401-402. 被引量:8
  • 3吴洵昳,洪震,吴逊,吴立文,赵忠新,王学峰,周东,吕传真.多中心双盲、随机、安慰剂对照评价左乙拉西坦添加治疗难治性部分性癫癎发作的疗效及安全性[J].中华神经科杂志,2007,40(3):149-153. 被引量:44
  • 4Wirrell EC.Benign epilepsy of childhood with centro-temporal spikes.Epilepsia,1998,39:S32-S41.
  • 5林传鼎,张厚粲主编.韦氏儿童智力量表中国修订本(WISC-CR).第1版.北京:北京师范大学出版社,1986.120.
  • 6Aldenkamp AP,de Krom M,Reijs R.Newer an tipe ileptic drugs and cognitive issuse.Epilepsia,2003,44(suppl4):S21-S29.
  • 7Lagae L.Cognitive side effects of anti-epileptic drugs Therelevance in childhood epilepsy.Seizure,2006,15:235-241.
  • 8Piazzini A,Chifari R,Canevini MP,et al.Levetiracetam:an improvement of attention and of oral fluency in patients with partial epilepsy.Epilepsy Res,2006,68:181.
  • 9Lynch BA,Lambeng N,Nocka K,et al.The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam[J].Proc Natl Acad Sci USA,2004,101(26):9861-9866.
  • 10Carreno M.Levetiracetam[J].Drugs Today(Barc),2007,43(11):769-794.

共引文献126

同被引文献40

  • 1肖波,刘献增,龙小艳,等.癫痫治疗学[M].北京.人民卫生出版社,2010:163-170.
  • 2吴瑞萍,胡亚美,江载芳.实用儿科学[M].7版.北京:人民卫生出版社,2008:1171.
  • 3Walker M C. Diagnosis and treatment of nonconvulsive status epilepticus [ J ]. CNS Drugs, 2001,15 ( 12 ) : 931- 939.
  • 4Visweswari G, Siva P K, Lokanatha V, et al. The antiep- ileptic effect of centella asiatica on the activities of Na ~/ K ~ , Mg2~ and Ca2~ -ATPases in rat brain during pentyle- netetrazol-induced epilepsy ~ J ]. Indian J Pharmacol, 2010,42(2) :82-86.
  • 5Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of p-glycoprotein and multidrug re- sistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis [ J ]. Epilepsy Res, 2006,68 ( 3 ) : 213-228.
  • 6Furuno T, Landi M T, Ceroni M, et al. Expression poly- morphism of the blood-brain barrier component p-glyco- protein (mdrl) in relation to parkinson ~s disease [ J ]. Pharmacogenetics, 2002,12 ( 7 ) :529-534.
  • 7Long Q, Qiu B, Liu W, et al. Functional recovery and neuronal regeneration of a rat model of epilepsy by trans- plantation of hesl-down regulated bone marrow stromal cells[ J]. Neuroscienee, 2012,212:214-224.
  • 8Koo D L, Joo E Y, Kim D, et al. Effects of levetiracetam as a monotherapy on bone mineral density and biochemi- cal markers of bone metabolism in patients with epilepsy [J]. Epilepsy Res, 2013,104(1-2) :134-139.
  • 9Wheless J W, Clarke D F, Arzimanoglou A. Treatment of pediatr epilepsy : European expert opinion,2007 [ J ]. Epi- leptic Disorders, 2007,22(4) :353-412.
  • 10Huffman J, Kossoff E H. State of the ketogenie diet (s) in epilepsy [ J ]. Curr Neurol Neurosei Rep, 2006,6 ( 4 ) : 332-340.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部